First-of-its-kind STARD(3) Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent

[Image: see text] STARD3 is a cellular protein that represents an attractive target for cancer therapy, being overexpressed in breast cancer and implied in the development of colorectal, gastric, and prostate cancers. Unfortunately, no STARD3 inhibitor has been identified yet. In this work, an in si...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:ACS Med Chem Lett
Autores principales: Lapillo, Margherita, Salis, Barbara, Palazzolo, Stefano, Poli, Giulio, Granchi, Carlotta, Minutolo, Filippo, Rotondo, Rossella, Caligiuri, Isabella, Canzonieri, Vincenzo, Tuccinardi, Tiziano, Rizzolio, Flavio
Formato: Artigo
Lenguaje:Inglês
Publicado: American Chemical Society 2019
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6466518/
https://ncbi.nlm.nih.gov/pubmed/30996782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.8b00509
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares